TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹9,620 Cr | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr | ₹7,673 Cr |
What is the latest Revenue of TORRENT PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹9,620 Cr |
Mar2023 | ₹8,508 Cr |
Mar2022 | ₹8,005 Cr |
Mar2021 | ₹7,939 Cr |
Mar2020 | ₹7,673 Cr |
How is Revenue of TORRENT PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹9,620 Cr | 13.07 | |
Mar2023 | ₹8,508 Cr | 6.29 | |
Mar2022 | ₹8,005 Cr | 0.82 | |
Mar2021 | ₹7,939 Cr | 3.47 | |
Mar2020 | ₹7,673 Cr | - |
Compare Revenue of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹107,235.6 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
MANKIND PHARMA | ₹94,475.7 Cr | -3.3% | -6.1% | 3.4% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -3.3% |
-1.4% |
9.8% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses